News & Highlights Matt Gunnison 7/10/23 Matt Gunnison 7/10/23 Univercells Technologies Acquired by Donaldson Company Read More Matt Gunnison 2/15/23 Matt Gunnison 2/15/23 Astrea Bioseparations to Combine with Biotage AB, Creating Global Chromatography Leader Read More Matt Gunnison 1/10/23 Matt Gunnison 1/10/23 Astrea Bioseparations Acquires Delta Precision Ltd, a Leading Manufacturer of Chromatography Columns for Biomanufacturing Read More Matt Gunnison 10/12/22 Matt Gunnison 10/12/22 Gamma Biosciences and Lonza Collaborate to Co-develop Reagents for Clinical Cell Selection in the Cocoon® Platform Read More Matt Gunnison 9/29/22 Matt Gunnison 9/29/22 Astrea Bioseparations Introduces Nereus LentiHERO®, a Fit-for-purpose Solution for Lentiviral Vector Purification Read More Matt Gunnison 3/22/22 Matt Gunnison 3/22/22 Gamma Biosciences Launches Initiative Through Mirus Bio to Develop Lipid-Polymer Nanocomplexes for In Vivo mRNA Delivery Read More Matt Gunnison 3/16/22 Matt Gunnison 3/16/22 Kieran P. Murphy, Former CEO Of GE Healthcare, Joins Gamma Biosciences as Executive Chairman Read More Matt Gunnison 12/14/21 Matt Gunnison 12/14/21 Dale Gordon Appointed CEO of Mirus Bio to Support GMP Expansion Read More Matt Gunnison 11/16/21 Matt Gunnison 11/16/21 BioMagnetic Solutions Confirms ISO Certifications and GMP Facility Build in the Innovation Park at Penn State Read More Matt Gunnison 9/23/21 Matt Gunnison 9/23/21 Gamma Biosciences Makes Strategic Investment in Process Analytics and Continuous Bioprocessing Company, Nirrin Technologies Read More Matt Gunnison 6/14/21 Matt Gunnison 6/14/21 Gamma Biosciences Names Terry Pizzie as CEO of Astrea Bioseparations Read More Matt Gunnison 5/18/21 Matt Gunnison 5/18/21 Gamma Biosciences Acquires Controlling Stake in Mirus Bio to Expand Reach in Gene Therapy and Next Generation Vaccines Read More Matt Gunnison 3/24/21 Matt Gunnison 3/24/21 Gamma Biosciences Makes Key Management Hires Read More Matt Gunnison 1/15/21 Matt Gunnison 1/15/21 Gamma Biosciences to Acquire BioMagnetic Solutions, Adding Novel Immunomagnetic Cell Separation Platform to Bioseparation Portfolio Read More Matt Gunnison 12/21/20 Matt Gunnison 12/21/20 Gamma Biosciences Announces Strategic Licensing Agreement by Astrea Bioseparations for Advanced Application of Avacta Affimer® Reagent Technology Read More Matt Gunnison 9/30/20 Matt Gunnison 9/30/20 Gamma Biosciences Acquires Nanopareil to Advance Next-Generation Purification Capabilities of Astrea Bioseparations Read More Matt Gunnison 5/5/20 Matt Gunnison 5/5/20 Launch of Univercells Technologies for intensified, automated technologies Read More Matt Gunnison 2/18/20 Matt Gunnison 2/18/20 KKR Forms Life Sciences Tools Platform Gamma Biosciences Read More
Matt Gunnison 7/10/23 Matt Gunnison 7/10/23 Univercells Technologies Acquired by Donaldson Company Read More
Matt Gunnison 2/15/23 Matt Gunnison 2/15/23 Astrea Bioseparations to Combine with Biotage AB, Creating Global Chromatography Leader Read More
Matt Gunnison 1/10/23 Matt Gunnison 1/10/23 Astrea Bioseparations Acquires Delta Precision Ltd, a Leading Manufacturer of Chromatography Columns for Biomanufacturing Read More
Matt Gunnison 10/12/22 Matt Gunnison 10/12/22 Gamma Biosciences and Lonza Collaborate to Co-develop Reagents for Clinical Cell Selection in the Cocoon® Platform Read More
Matt Gunnison 9/29/22 Matt Gunnison 9/29/22 Astrea Bioseparations Introduces Nereus LentiHERO®, a Fit-for-purpose Solution for Lentiviral Vector Purification Read More
Matt Gunnison 3/22/22 Matt Gunnison 3/22/22 Gamma Biosciences Launches Initiative Through Mirus Bio to Develop Lipid-Polymer Nanocomplexes for In Vivo mRNA Delivery Read More
Matt Gunnison 3/16/22 Matt Gunnison 3/16/22 Kieran P. Murphy, Former CEO Of GE Healthcare, Joins Gamma Biosciences as Executive Chairman Read More
Matt Gunnison 12/14/21 Matt Gunnison 12/14/21 Dale Gordon Appointed CEO of Mirus Bio to Support GMP Expansion Read More
Matt Gunnison 11/16/21 Matt Gunnison 11/16/21 BioMagnetic Solutions Confirms ISO Certifications and GMP Facility Build in the Innovation Park at Penn State Read More
Matt Gunnison 9/23/21 Matt Gunnison 9/23/21 Gamma Biosciences Makes Strategic Investment in Process Analytics and Continuous Bioprocessing Company, Nirrin Technologies Read More
Matt Gunnison 6/14/21 Matt Gunnison 6/14/21 Gamma Biosciences Names Terry Pizzie as CEO of Astrea Bioseparations Read More
Matt Gunnison 5/18/21 Matt Gunnison 5/18/21 Gamma Biosciences Acquires Controlling Stake in Mirus Bio to Expand Reach in Gene Therapy and Next Generation Vaccines Read More
Matt Gunnison 1/15/21 Matt Gunnison 1/15/21 Gamma Biosciences to Acquire BioMagnetic Solutions, Adding Novel Immunomagnetic Cell Separation Platform to Bioseparation Portfolio Read More
Matt Gunnison 12/21/20 Matt Gunnison 12/21/20 Gamma Biosciences Announces Strategic Licensing Agreement by Astrea Bioseparations for Advanced Application of Avacta Affimer® Reagent Technology Read More
Matt Gunnison 9/30/20 Matt Gunnison 9/30/20 Gamma Biosciences Acquires Nanopareil to Advance Next-Generation Purification Capabilities of Astrea Bioseparations Read More
Matt Gunnison 5/5/20 Matt Gunnison 5/5/20 Launch of Univercells Technologies for intensified, automated technologies Read More
Matt Gunnison 2/18/20 Matt Gunnison 2/18/20 KKR Forms Life Sciences Tools Platform Gamma Biosciences Read More